Lesson’s Learned from Building out the Commercial Organization

SK Life Science breaks through Covid barriers to bring epilepsy drug to market

Lutronic’s Focus on Change during the Pandemic

From Big Pharma to Startup: What are the Challenges?

The View from Olympus: How This MedTech Leader Approached the Pandemic

DENTALEZ COO Heather Trombley on Reinvigorating the Company

Seqirus Exec on Vaccine Differentiation

Zimmer Biomet VP on Covering the Territory

How Teleflex Grew its Market Value 4x in 6 Years

Admedus COO David St. Denis on Courage, Commitment and Conversation

- 1 min read

Harmony Biosciences (HRMY) Appoints Jeffrey M. Dayno as President and CEO

Montgomery County, PA, April 24, 2023 (StreetInsider) -- Harmony Biosciences Holdings, Inc., a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced that Jeffrey M. Dayno, M.D., has been appointed President and Chief Executive Officer by the Company's Board of Directors and has been elected to join as a member of the Board.

Read full article here.

Recent Posts

See All

Boundless Bio Secures $100M Series C Funding to Advance ecDNA-Directed Therapies for Oncogene Cancer

San Diego, CA, May 16, 2023 (Business Wire) -- Boundless Bio, a pioneering precision oncology company, has successfully raised $100 million in a Series C financing round led by Leaps by Bayer and RA

Vitor Rocha Takes the Helm as President of Cepheid, Driving Global Healthcare Innovations

Sunnyvale, CA, May 23, 2023 (Cepheid) -- Cepheid, a renowned molecular diagnostics company, has appointed Vitor Rocha as its new President. With over 20 years of experience in the medical devices in

ReNAgade Therapeutics Secures $300 Million Series A Funding to Revolutionize RNA Medicine

Cambridge, MA, May 23, 2023 (Business Wire) -- ReNAgade Therapeutics, a cutting-edge company focused on harnessing the full potential of RNA medicines for disease correction, has successfully raised

Boundless Bio Secures $100M Series C Funding to Advance ecDNA-Directed Therapies for Oncogene Cancer

Vitor Rocha Takes the Helm as President of Cepheid, Driving Global Healthcare Innovations

ReNAgade Therapeutics Secures $300 Million Series A Funding to Revolutionize RNA Medicine

Dave Rosa named President of Intuitive

ElevateBio Secures $401M Series D Financing, Spearheading Advancements in Cell and Gene Therapies

Syneos Health to be Acquired for Approximately $7.1 Billion by a Private Investment Consortium

DermTech names Bret Christensen, former chief commercial officer of Insulet, as its new President

Healthy.io raises $50 million in series D funding to accelerate adoption of at-home kidney test

Ron Renaud Appointed to Lead Cerevel Therapeutics as President and Chief Executive Officer

Baxter to sell biopharma unit for $4.25 billion

Executive Spotlights

Harmony Biosciences (HRMY) Appoints Jeffrey M. Dayno as President and CEO

Recent Posts

Life Science Headlines